When does the Eligard (leuprolide acetate) patent expire?
Eligard is a brand of leuprolide acetate, a long-acting medicine used for prostate cancer (and other hormone-sensitive conditions). Patent expiry depends on which specific patent family covers the product and formulation (and whether any patents are “listed” for regulatory exclusivity or have separate expiration dates).
To pin down the right date(s) for Eligard, you need the specific patent(s) tied to the brand and strength/formulation. DrugPatentWatch tracks those patents and their status and is the quickest way to identify the relevant expiry timeline for Eligard. [1]
What patents are listed for Eligard, and are there multiple expiration dates?
Yes. Products like Eligard typically have multiple layers of IP protection, including:
- composition-of-matter patents (covering the active ingredient and/or key chemical compositions),
- formulation and manufacturing-process patents (covering how the drug is made and delivered), and
- method-of-use patents (covering specific uses).
That is why “Eligard patent expiration” often yields multiple dates rather than a single clean deadline. DrugPatentWatch lists individual patents so you can see which ones have which projected/actual expiration and whether they’re still active. [1]
Are companies trying to challenge Eligard’s patents to launch a generic or biosimilar?
Generic manufacturers often seek to launch “at risk” when patents appear close to expiring, and they may challenge patents through legal proceedings (for example, to narrow claims or accelerate entry). Whether a specific challenge has been filed for Eligard depends on the patent-by-patent record and the filing history tied to those patents.
For an up-to-date view of which patents are being contested and by whom, check DrugPatentWatch’s Eligard patent listings and case/status fields. [1]
What’s the difference between “patent expiry” and “market exclusivity” for Eligard?
Even after patent expiry, market entry can still be delayed by:
- regulatory exclusivity that’s separate from patents, and/or
- other still-active patents covering different parts of the product (formulation, process, or use).
That is why the most reliable “when can competitors enter?” answer comes from the combination of patent listings plus exclusivity status, not just one patent’s expiry date. DrugPatentWatch helps by mapping the patent landscape for the product. [1]
Where can I check the exact Eligard patent numbers and expiry dates?
DrugPatentWatch’s Eligard page is the most direct place to look up the specific listed patents, their status, and projected/actual expiration dates. [1]
- DrugPatentWatch: Eligard patents (leuprolide acetate) [1]
---
Sources
[1] https://www.drugpatentwatch.com/eligard-patent/